Status:
COMPLETED
Clinical Trial of Chemosensitivity Test
Lead Sponsor:
Japan Clinical Cancer Research Organization
Collaborating Sponsors:
Kitasato University
Conditions:
Gastric Cancer
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
Brief Summary
To evaluate the usefulness of chemosensitivity test in evaluating the appropriate adjuvant cancer chemotherapy after gastric surgery
Detailed Description
Patients: clinical Stage III gastric cancer patients. Informed consent will be obtained before surgery. Eligible patients: surgical Stage II, IIIA and IIIB gastric cancer patients. Chemosensitivity te...
Eligibility Criteria
Inclusion
- histologically proven gastric cancer
- PS (ECOG) 0 or 2
- D2 dissection, curability B or more
- surgical Stage IIIA and IIIB
- negative peritoneal cytology
- no previous radiotherapy, chemotherapy and hormone therapy
- possible peroral intake at 6 POW
- no severe surgical complication
- normal bone marrow, liver and renal function
- complete chemosensitivity test
- written informed consent
Exclusion
- multiple cancer
- contraindication for S-1
- history of drug allergy (grade 3)
- severe complication
- watery diarrhea
- pregnant
- scirrhous gastric cancer
- the other patients who was judged as inadequate for trial by doctor on duty
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00287755
Start Date
March 1 2006
End Date
March 1 2011
Last Update
June 29 2011
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya University Hospital
Nagoya, Aichi-ken, Japan, 466-8550
2
Department of frontier surgery,Draduate school of medicine,Chiba University
Chiba, Chiba, Japan, 260-8670
3
Kyusyu University Faculty of Medical Sciences
Fukuoka, Fukuoka, Japan, 812-8582
4
Kyusyu Central Hospital of the Mutual Aid Association of Public School Teachers
Fukuoka, Fukuoka, Japan, 815-8588